Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 306

1.

Evolution, controversies and the future of prostate cancer grading.

Egevad L, Delahunt B, Yaxley J, Samaratunga H.

Pathol Int. 2019 Feb;69(2):55-66. doi: 10.1111/pin.12761. Epub 2019 Jan 29. Review.

PMID:
30694570
3.

Handling and Reporting of Pelvic Lymphadenectomy Specimens in Prostate and Bladder Cancer: A Web-based Survey by the European Network of Uropathologists (ENUP).

Prendeville S, Berney DM, Bubendorf L, Compérat E, Egevad L, Hes O, Kristiansen G, Oxley J, van Leenders GJLH, Varma M, van der Kwast T.

Histopathology. 2019 Jan 3. doi: 10.1111/his.13818. [Epub ahead of print]

PMID:
30604878
4.

Grading of renal cell carcinoma.

Delahunt B, Eble JN, Egevad L, Samaratunga H.

Histopathology. 2019 Jan;74(1):4-17. doi: 10.1111/his.13735. Review.

PMID:
30565310
5.

Prostate cancer induces C/EBPβ expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome.

Adamo H, Hammarsten P, Hägglöf C, Dahl Scherdin T, Egevad L, Stattin P, Halin Bergström S, Bergh A.

Prostate. 2019 Apr;79(5):435-445. doi: 10.1002/pros.23749. Epub 2018 Dec 11.

PMID:
30536410
6.

The current status of renal cell carcinoma and prostate carcinoma grading.

Delahunt B, Egevad L, Yaxley J, Samaratunga H.

Int Braz J Urol. 2018 Nov-Dec;44(6):1057-1062. doi: 10.1590/S1677-5538.IBJU.2018.06.01. No abstract available.

7.

Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Egevad L, Judge M, Delahunt B, Humphrey PA, Kristiansen G, Oxley J, Rasiah K, Takahashi H, Trpkov K, Varma M, Wheeler TM, Zhou M, Srigley JR, Kench JG.

Pathology. 2019 Jan;51(1):11-20. doi: 10.1016/j.pathol.2018.10.003. Epub 2018 Nov 23.

PMID:
30477882
8.

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.

Mayrhofer M, De Laere B, Whitington T, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert E, De Maeseneer D, Strijbos M, Bols A, Fransis K, Oeyen S, van Dam PJ, Van den Eynden G, Rutten A, Aly M, Nordström T, Van Laere S, Rantalainen M, Rajan P, Egevad L, Ullén A, Yachnin J, Dirix L, Grönberg H, Lindberg J.

Genome Med. 2018 Nov 21;10(1):85. doi: 10.1186/s13073-018-0595-5.

9.

A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis.

Sjöberg E, Frödin M, Lövrot J, Mezheyeuski A, Johansson M, Harmenberg U, Egevad L, Sandström P, Östman A.

Br J Cancer. 2018 Oct;119(7):840-846. doi: 10.1038/s41416-018-0266-8. Epub 2018 Oct 8.

PMID:
30293996
10.

Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.

Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Coughlin G, Dunglison N, Gianduzzo T, Kua B, Malone G, Martin B, Preston J, Pokorny M, Wood S, Samaratunga H.

Histopathology. 2019 Jan;74(2):284-290. doi: 10.1111/his.13737. Epub 2018 Oct 17.

PMID:
30129659
11.

Macroscopic features of prostate cancer.

Lindh C, Delahunt B, Egevad L.

Pathology. 2018 Jun;50(4):382-388. doi: 10.1016/j.pathol.2018.01.002. Epub 2018 Apr 27.

PMID:
29709289
12.

Re: Comment on Egevad et al., 'Utility of Pathology Imagebase for standardisation of prostate cancer grading'.

Egevad L, Samaratunga H, Delahunt B.

Histopathology. 2018 Aug;73(2):361-362. doi: 10.1111/his.13637. Epub 2018 May 30. No abstract available.

PMID:
29672898
13.

Intraoperative Consultation and Macroscopic Handling: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations.

Verrill C, Perry-Keene J, Srigley JR, Zhou M, Humphrey PA, Lopez-Beltran A, Egevad L, Ulbright TM, Tickoo SK, Epstein JI, Compérat E, Berney DM; Members of the ISUP Testicular Tumor Panel.

Am J Surg Pathol. 2018 Jun;42(6):e33-e43. doi: 10.1097/PAS.0000000000001049.

PMID:
29579010
14.

Utility of Pathology Imagebase for standardisation of prostate cancer grading.

Egevad L, Delahunt B, Berney DM, Bostwick DG, Cheville J, Comperat E, Evans AJ, Fine SW, Grignon DJ, Humphrey PA, Hörnblad J, Iczkowski KA, Kench JG, Kristiansen G, Leite KRM, Magi-Galluzzi C, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, True LD, Tsuzuki T, van der Kwast T, Varma M, Zhou M, Clements M.

Histopathology. 2018 Jul;73(1):8-18. doi: 10.1111/his.13471. Epub 2018 Mar 5.

PMID:
29359484
15.

The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential.

Ström P, Nordström T, Aly M, Egevad L, Grönberg H, Eklund M.

Eur Urol. 2018 Aug;74(2):204-210. doi: 10.1016/j.eururo.2017.12.028. Epub 2018 Jan 10.

16.

Handling and reporting of transperineal template prostate biopsy in Europe: a web-based survey by the European Network of Uropathology (ENUP).

Kammerer-Jacquet SF, Compérat E, Egevad L, Hes O, Oxley J, Varma M, Kristiansen G, Berney DM.

Virchows Arch. 2018 Apr;472(4):599-604. doi: 10.1007/s00428-017-2265-1. Epub 2018 Jan 11.

PMID:
29327138
17.

Fuhrman grading is inappropriate for papillary renal cell carcinoma.

Delahunt B, Egevad L, Srigley JR, Samaratunga H.

World J Urol. 2018 Aug;36(8):1335-1336. doi: 10.1007/s00345-017-2153-y. Epub 2017 Dec 18. No abstract available.

PMID:
29256019
18.

Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations.

Egevad L, Delahunt B, Kristiansen G, Samaratunga H, Varma M.

Pathology. 2018 Jan;50(1):60-73. doi: 10.1016/j.pathol.2017.09.008. Epub 2017 Dec 6. Review.

PMID:
29199015
19.

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.

Yaxley JW, Dagher J, Delahunt B, Egevad L, Srigley J, Samaratunga H.

World J Urol. 2018 Jan;36(1):15-20. doi: 10.1007/s00345-017-2119-0. Epub 2017 Nov 7.

PMID:
29116393
20.

Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.

Kristiansen A, Drevin L, Delahunt B, Samaratunga H, Robinson D, Franck Lissbrant I, Stattin P, Egevad L.

Pathology. 2017 Dec;49(7):715-720. doi: 10.1016/j.pathol.2017.08.008. Epub 2017 Oct 14.

PMID:
29037803

Supplemental Content

Loading ...
Support Center